Back to results
CompletedPhase 1Phase 2

Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist Devices

NCT02547766

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Utah

Salt Lake City, Utah, United States

View on ClinicalTrials.gov